NeuroPace (NPCE) Stock Price, Quote, News & History

Q: What sector and industry does NeuroPace (NPCE) operate in?

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

Comments

NeuroPace Inc (NPCE) Stock Price, Quote, News & History

NPCENASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$15.67

0.181.16%

At close: Feb 6, 4:00 PM EST

$15.47

-0.20-1.28%

After Hours: Feb 6, 4:00 AM EST

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$15.79

Close

$15.67

Volume / Avg.

123.24K / 249.58K

Day Range

$15.31 - $15.98

52 Wk Range

7.56 - 18.98

Market Cap

$515.27M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

4.5%

Days to Cover

2.55

Recent Neuropace Inc News

Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Benzinga Senior Editor

This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-16.31M

Investing Cash Flow (TTM)

1.73M

Financing Cash Flow (TTM)

19.81M

Free Cash Flow (TTM)

-16.58M

Capital Expenditure (TTM)

-274.00K

Net Change in Cash (TTM)

5.23M

Analyst Trends and Forecast

1

Aug 25

2

Nov 25

2

Dec 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$533.43M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

5.20

PB Ratio (TTM)

27.84

Earnings Yield % (TTM)

-4.84%

Earnings Yield % (FWD)

-4.19%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.56

Company Debt

Total Debt

$58.75M

LT Debt

$58.75M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$20.65M

Debt to Equity

3.84

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$15.79

Close

$15.67

Volume / Avg.

123.24K / 249.58K

Day Range

$15.31 - $15.98

52 Wk Range

7.56 - 18.98

Market Cap

$515.27M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

4.5%

Days to Cover

2.55

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sa...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy NeuroPace (NPCE) stock?

A

You can purchase shares of NeuroPace (NASDAQ:NPCE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are NeuroPace (NPCE) competitors?

A

Other companies in NeuroPace’s space includes: CeriBell Inc (NASDAQ:CBLL), SI-BONE Inc (NASDAQ:SIBN), Sight Sciences Inc (NASDAQ:SGHT), Carlsmed Inc (NASDAQ:CARL) and Varex Imaging Corp (NASDAQ:VREX).

Q

What is the forecast, or price target, for NeuroPace (NPCE) stock?

A

NeuroPace has a consensus price target of $17.18.

Q

What is the current price for NeuroPace (NPCE)?

A

The stock price for NeuroPace (NASDAQ: NPCE) is $15.47 last updated February 6, 2026 at 4:00 AM EST.

Q

Does NeuroPace (NPCE) pay a dividend?

A

There are no upcoming dividends for NeuroPace.

Q

When is NeuroPace (NASDAQ:NPCE) reporting earnings?

A

NeuroPace does not have any upcoming earnings scheduled.

Q

Is NeuroPace (NPCE) going to split?

A

There is no upcoming split for NeuroPace.

Q

What sector and industry does NeuroPace (NPCE) operate in?

A

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

People Also Watch

Butterfly Network Inc

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$15.79

Close

$15.67

Volume / Avg.

123.24K / 249.58K

Day Range

$15.31 - $15.98

52 Wk Range

7.56 - 18.98

Market Cap

$515.27M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

4.5%

Days to Cover

2.55

Recent Neuropace Inc News

Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Benzinga Senior Editor

This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-16.31M

Investing Cash Flow (TTM)

1.73M

Financing Cash Flow (TTM)

19.81M

Free Cash Flow (TTM)

-16.58M

Capital Expenditure (TTM)

-274.00K

Net Change in Cash (TTM)

5.23M

Analyst Trends and Forecast

1

Aug 25

2

Nov 25

2

Dec 25

1

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$533.43M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

5.20

PB Ratio (TTM)

27.84

Earnings Yield % (TTM)

-4.84%

Earnings Yield % (FWD)

-4.19%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.56

Company Debt

Total Debt

$58.75M

LT Debt

$58.75M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$20.65M

Debt to Equity

3.84

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$15.79

Close

$15.67

Volume / Avg.

123.24K / 249.58K

Day Range

$15.31 - $15.98

52 Wk Range

7.56 - 18.98

Market Cap

$515.27M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

4.5%

Days to Cover

2.55

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sa...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry